Moingeon P, Stebbins C C, D'Adamio L, Lucich J, Reinherz E L
Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, MA 02115.
Eur J Immunol. 1990 Aug;20(8):1741-5. doi: 10.1002/eji.1830200818.
In order to characterize the CD3 zeta-related protein found in human natural killer (NK) cells and compare it with CD3 zeta expressed in T lymphocytes, the present study was performed. A polyclonal CD3-CD16+NK population displaying a strong non-major histocompatibility complex-restricted cytotoxic activity against the NK target K-562 was isolated and a product corresponding to CD3 zeta amplified using the polymerase chain reaction method. This 0.6-kb product was present in similar amounts in NK cells and T cells. In contrast, a product corresponding to CD3 delta was amplified from T lymphocytes exclusively. Thus, the CD3 zeta product detected in NK cells did not originate from contaminating T cells. DNA sequence analysis of two independent polymerase chain reaction products from the NK cells demonstrates that human NK cells and mature T cells share a CD3 zeta subunit with an identical primary amino acid sequence. The nucleotide sequence of a third NK-derived cDNA revealed an insertion of a CAG triplet encoding an additional glutamine residue in the cytoplasmic domain. Since this residue is encoded by nucleotides at a putative RNA splice junction, it possibly results from a difference in pre-mRNA splicing. Taken together, these data show that CD3 zeta is not structurally distinct in NK cells and in T lymphocytes.
为了鉴定在人类自然杀伤(NK)细胞中发现的与CD3 ζ相关的蛋白,并将其与T淋巴细胞中表达的CD3 ζ进行比较,开展了本研究。分离出一个多克隆CD3 - CD16 + NK细胞群体,其对NK靶细胞K - 562表现出强烈的非主要组织相容性复合体限制的细胞毒性活性,并使用聚合酶链反应方法扩增出与CD3 ζ对应的产物。这个0.6 kb的产物在NK细胞和T细胞中的含量相似。相比之下,仅从T淋巴细胞中扩增出与CD3 δ对应的产物。因此,在NK细胞中检测到的CD3 ζ产物并非源自污染的T细胞。对来自NK细胞的两个独立聚合酶链反应产物进行的DNA序列分析表明,人类NK细胞和成熟T细胞共享一个具有相同一级氨基酸序列的CD3 ζ亚基。第三个源自NK的cDNA的核苷酸序列显示,在细胞质结构域中插入了一个编码额外谷氨酰胺残基的CAG三联体。由于该残基由假定的RNA剪接连接处的核苷酸编码,它可能是由前体mRNA剪接差异导致的。综上所述,这些数据表明CD3 ζ在NK细胞和T淋巴细胞中的结构并无差异。